Coagulation factors and fibrin polymerization scaffold

The Coagulation factors and fibrin polymerization scaffold refers to the complex network of proteins and biochemical reactions responsible for blood clot formation and stabilization. This system comprises a series of inactive zymogens, known as coagulation factors (e.g., Factor II, VII, IX, X, XI, and XII), which are activated in a cascading fashion to generate thrombin (StatPearls, 2023). Thrombin then catalyzes the conversion of soluble fibrinogen into fibrin monomers, which polymerize to form a structural scaffold that traps platelets and red blood cells (UniProt, P02671). This scaffold is further stabilized by Factor XIIIa-mediated cross-linking to ensure hemostatic integrity. In pathological states, such as deep vein thrombosis or atrial fibrillation, this system is overactive, leading to life-threatening clots. Therapeutic strategies target various points in this pathway: anticoagulants like heparin and direct oral anticoagulants (DOACs) inhibit specific proteases to prevent clot expansion, while thrombolytic agents like tissue plasminogen activator (tPA) promote the degradation of the fibrin scaffold to restore blood flow (PubMed, PMID: 30033778).

Other names

Blood coagulation cascadeClotting factorsFibrinogen-fibrin systemHemostatic system

Inhibition of serine proteases (Factor Xa, Thrombin), Vitamin K epoxide reductase inhibition, and enzymatic degradation of fibrin polymers (NIH, 2022; PubMed, PMID: 30033778).